Journals / MN Kardiyoloji / 2006 / Cilt: 13 - Sayı: 6

Primary hyperparathyroidism and ıts effect on cardiovascular system

Primer hiperparatiroidzm ve kardiovasküler sisteme etkisi

Pages
387–391
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

But, the influences of pHPT on functional properties still remains as an issue that requires more study about it.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It has been reported that symptomatic cases of primary hyperparathyroidism have increased cardiovascular mortality rates. pHPT is known to be associated with hypertension, disturbances in the renin-angiotensin-aldosterone system, and structural and functional alterations in the vascular wall.
📊
Key Findings & Data:Besides the structural heart diseases such as left ventricular hypertrophy and valvular and myocardial calcifications, the prevalance of disturbances in functional properties of the heart has also been reported to be increased in this population.
💡
Conclusion & Impact:But, the influences of pHPT on functional properties still remains as an issue that requires more study about it.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kalp damar sistemi · Hiperkalsemi · Hipertrofi

Abstract

It has been reported that symptomatic cases of primary hyperparathyroidism have increased cardiovascular mortality rates. pHPT is known to be associated with hypertension, disturbances in the renin-angiotensin-aldosterone system, and structural and functional alterations in the vascular wall. Besides the structural heart diseases such as left ventricular hypertrophy and valvular and myocardial calcifications, the prevalance of disturbances in functional properties of the heart has also been reported to be increased in this population. But, the influences of pHPT on functional properties still remains as an issue that requires more study about it.

Özet

Semptomatik primer hiperparatiroidi (PHPT)'li hastalarda kardiyovasküler ölüm sıklığının artmış olduğu bugüne dek çeşitli yayınlarda bildirilegelmiştir. Primer hiperparatiroidi, hipertansiyon, renin anjiotensin aldosteron sistemindeki değişiklikler, kardiyak aritmiler ve vasküler sistemdeki yapısal ve fonksiyonel değişiklikler ile ilişkili olduğu bilinmektedir. Sol ventrikül hipertrofisi, valvüler ve miyokardiyal kalsifikasyon gibi yapısal kalp hastalıkları yanı sıra, kalbin fonksiyonel özelliklerindeki bozukluklarının da sıklığının, bu hastalarda artmış olduğu bildirilmiştir. Ancak, PHPT'in fonksiyonel özelliklere olan etkisi, hala, üzerinde daha fazla çalışmayı gerektiren bir konu olarak kalmıştır.

🔖

Cite This Article

BİTİGEN, A., ERKOL, A., ODUNCU, V., KIRMA, C. (2006). Primary hyperparathyroidism and ıts effect on cardiovascular system. MN Kardiyoloji, Cilt: 13 - Sayı: 6, 387–391. https://ajindex.com/articles/297785

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Ogino K, Burkhoff D, Bilezikian JP. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH- related protein. Endocrinology 1995; 136:3024-30.
  2. Schluter KD, Weber M, Piper HM. Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem J 1995; 310:439-44.
  3. Baczynski R, Massry SG,. Kohan R, Magott M, Saglikes Y, Brautbar N. Effect of parathyroid hormone on myocardial energy metabolism in the rat. Kidney Int 1985; 27:718-25.
  4. Bogin E, Massry SG, Harary I. Effect of parathyroid hormone on rat heart cells. J Clin Invest 1981; 67:1215-27. Hedback G,Tiselli LE,Bengtsson BA, Hedman l,Oden A. Premature death in patients operated on for primary hyperparathyroidism. World J Surg 1990; 14:829-36. Hedbâck G, Oden A. Increased risk of death from primary hy­ perparathyroidism an update. EurJ Clin Invest 1.998; 28:277-8.
  5. Palmer M, Adami HO, Bergstrom R, Akerstom G, Liunghall S.Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 1987; 102:1-7. Lafferty F. Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension and discriminant analysis of laboratory tests. Arch Intern Med 1986; 141:1761. Kovacs L, Goth Ml, Szabolcs I et al. The effect of surgical treatment on secondary hyperaldosteronism and the relative hyperinsulinemia in primary hyperparathyroidism. Eur J Endocrinol 1998; 138:543-7.
  6. Rayner HC, Hoskind DJ. Hyperparathyroidism associated with severe hypercalcemia and myocardial calcification despite minimal bone disease. Br Med J 1986;293:1277-8.
  7. Stefenelli T, Wikman-Coffelt J, Wu ST et al. Calcium-dependent fluorescence transients during ventricular fibrillation. Am Heart J 1990; 120:590-7.
  8. Curione M, Letizia C, Amato S et al. Increased risk of cardiac death in primary hyperparathyroidism:What is a role of electrical instability? International Journal of Cardiology 2006(in press) Dubois F., Charlier P, Solal AC, Passa P, Gourgon R. Primary hyperparathyroidism disclosed by heart arrhythmia.Arch Mai Coeur Vaiss 1989; 82(12):2071 -2074.
  9. Shah AP, Lopez A, Wachsner R.Meymandi SK, El-Bialy AK,Ichiuji AM. Sinus node dysfunction secondary to hyperparathyroidism J Cardiovasc Pharmacol Therapeut 9(2): 145-147,2004.
  10. Nuzzo V, Tauchmanova L, Fonderico F et al. Increased intimamedia thickness of the carotid artery wall, normal blo